Uses of Amxolmuc

Amxolmuc drug is a product of Pymepharco Joint Stock Company - Vietnam, which is used in the treatment of lower respiratory tract diseases. On the market today, there is a lot of information about Amxolmuc drug products, but it is still incomplete. To better understand what Amxolmuc is, what are the uses of Amxolmuc, let's learn more in the article below.

Amxolmuc has the main ingredient Ambroxol Hydrochloride, which belongs to the group of cough and cold medicines. The drug is made in the form of 30mg capsules, blister packs of 10 tablets, boxes of 10 blisters, manufactured by Pymepharco pharmaceutical company.
Amxolmuc is an OTC drug indicated for the treatment of acute and chronic diseases of the respiratory tract accompanied by abnormal bronchial secretions, especially in acute exacerbations of chronic bronchitis, bronchial asthma, bronchitis. asthmatic form.
Brand name: The registered name is Amxolmuc.
Presentation: The drug is in the form of hard capsules.
Packing: The drug is packed in: Box of 10 blisters x 10 tablets.
Classification: Amxolmuc is an OTC drug – an over-the-counter drug.
Registration number: Registration number is VD-25378-16
Shelf life: The shelf life of the drug is 36 months from the date of manufacture.
Place of manufacture: The drug is manufactured at Pymepharco Joint Stock Company
Address: 166 - 170 Nguyen Hue, Tuy Hoa, Phu Yen, Vietnam.

2.1. Pharmacodynamic properties of the drug Amxolmuc 30 mg Amxolmuc drug is prescribed by doctors in the following cases:
Symptomatic treatment for patients with asthmatic bronchitis, bronchial asthma, chronic bronchitis or some diseases acute or chronic other respiratory tract. Prevention of pulmonary complications in patients after a respiratory emergency or recent surgery. Active ingredient Ambroxol is a metabolite derived from bromhexin, this active ingredient has the same effect and effect as bromhexine. It is the effect of thinning and loosening phlegm, clearing mucus in the respiratory tract. As a result, Ambroxol is frequently selected by manufacturers as the main ingredient in therapeutic support products to reduce the number of exacerbations and improve symptoms in bronchitis, bronchial asthma, or bronchitis. form of asthma, chronic bronchitis, bronchial asthma with the main active ingredient is ambroxol hydrochloride with a content of 30mg, also known as Amxolmuc hcl 30mg.
2.2. Pharmacokinetic properties of the drug Amxolmuc 30 mg * Absorption
Ambroxol is absorbed almost completely and very rapidly at therapeutic doses. Maximum plasma concentrations are reached within half an hour to 3 hours after dosing.
Amxolmuc is approximately 90% bound to plasma proteins.
* Distribution
Ambroxol diffuses rapidly from the blood to body tissues with the highest concentrations in the lungs. The half-life of the drug in plasma ranges from 7 to 12 hours.
* Metabolism
Active ingredient Ambroxol is metabolized mainly in the liver.
* Elimination
Total amount of drug excreted by the kidneys is about 90%. Of which, about 30% of the oral dose is eliminated via the first cycle of absorption into the body.
2.3. Contraindications of Amxolmuc 30 mg - Patients who are allergic or have a history of allergy to any of the ingredients in Amxolmuc
- Patients with peptic ulcer - advanced stage
2.4. Side effects when taking Amxolmuc In addition to the effects that Amxolmuc gives you, the side effects listed below are inevitable:
Because the drug is well tolerated, there may be mild side effects on the road. Upper digestive tract: mainly dyspepsia, belching, rarely nausea, vomiting, Uncommon: allergic reaction, mainly rash. Rare: acute anaphylactoid reaction, severe, but not certain to be related to ambroxol; dry mouth, and increased transaminases.
2.5. Drug interactions During drug use, there may be competition or interactions between Amxolmuc with food or other drugs and supplements such as:
Taking Ambroxol with antibiotics (Amoxicillin, Cefuroxim). , Erythromycin , Doxycyclin ...) increases the concentration of antibiotics in the lung parenchyma. Do not combine Ambroxol with an antitussive (eg Codeine) or a expectorant (eg atropin): The combination is not reasonable and may cause more undesirable effects. Patients should list all the drugs and supplements they are taking so that medical staff can advise on drug use regimens as well as avoid unwanted drug interactions.
2.6. Note when using the drug Amxolmuc hcl 30 mg Patients when using the drug should pay attention to some cases as follows:
The drug does not cause drowsiness or distraction, so users can still study, drive, operate. machines or do tasks that require intense concentration. The drug should not be used in patients with ulcers in the digestive system, because the drug causes mild irritation of the gastric mucosa. Use caution when using the drug when the patient is coughing up blood, because ambroxol can dissolve fibrin clots and cause bleeding again. Amxolmuc hard capsules contain lactose monohydrate - used as an inactive ingredient, caution should be exercised in patients with rare hereditary problems of lactose intolerance due to intestinal lactase deficiency or glucose-galactose malabsorption due to can lead to abdominal pain, diarrhea, flatulence, discomfort. Do not take the drug with alcoholic beverages, stimulants because it can reduce the desired effect of the drug. Use the correct dose as prescribed by the doctor, do not arbitrarily increase the dose or reduce the dose to achieve the best results. It is necessary to consult a doctor before using this medicine for pregnant women especially for the first trimester, it is better to take the lowest dose for the shortest possible time to be safe. . There are no studies to prove that Amxolmuc is excreted in breast milk or not, so caution should be exercised when used in lactating women.

3.1. How to take The drug is made in the form of a hard capsule, so do not crush or break the pill yourself before taking it, but drink the whole pill Take the pill with boiled water to get the best effect of Amxolmuc. take medicine after meals. 3.2. Dosage Dosage for adults and children over 10 years old:
Initial dose: 1 tablet each time, 3 times a day Maintenance dose: 1 tablet, 2 times a day For children under 10 years old need Consult your doctor before use to have the right dose to avoid possible unfortunate consequences.
3.3. Overdose There have not been any cases of fatal overdose reported, but if they do occur, contact your doctor and initiate symptomatic treatment.
Treatment of overdose There are no specific reports of overdose symptoms in humans. If an overdose occurs, you should immediately notify your doctor or go to the nearest medical facility to receive appropriate symptomatic treatment.
3.4. What to do when you miss a dose If you miss a dose, take it as soon as possible. If it is almost time for the next dose, take the usual dose, do not take a double dose to make up for the missed dose.

Storage conditions The drug should be stored in a cool, dry place below 30°C and protected from light.
Storage period The storage period is 36 months from the date of manufacture.